Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Currently Recruiting

The following studies are either currently enrolling new patients or are pending approval by the Institutional Review Board and should be enrolling shortly:


The studies below have completed patient enrollment in the last year at Cole Eye Institute and are in follow-up:

  • A 16 week evaluation of Novartis Health Management Tool in assessing self-test visual function in patients with AMD treated with Lucentis.
  • A Phase II Multicenter, Prospective, Randomized, Comparator Controlled, Dose Ranging Study Evaluating PF-04523655 Versus Ranibizumab in the Treatment of Subjects with Choroidal Neovascularization (MONET Study).
  • A Phase II Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration (GSK AMD).
  • Infant Aphakia Treatment Study (IATS)
  • An Open-Label, Multicenter, Phase II Trial of Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis (HUMIRA).
  • A Clinical Safety and Efficacy Comparison of Nevanac® 0.1% to Vehicle Following Cataract Surgery in Diabetic Retinopathy Patients (NEVANAC).
  • A Randomized, Double-masked, Sham-controlled Phase 3 Study of the Efficacy, Safety and Tolerability of Repeated Intravitreal Administration of VEGF Trap-Eye in Subjects With Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO).
  • A Randomized, Double Masked, Active Controlled Phase III Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration (VEGF Trap).
  • A Phase I open-label, dose escalation trial of REDD14NP delivered by a single intravitreal injection to patients with choroidal neovascularization secondary to exudative Age-related Macular Degeneration. (QUARK)

Schedule an Appointment Online

Call us for an Appointment

To find a Cole Eye Institute specialist for your needs, contact us at 216.444.2020 (or toll-free 800.223.2273, ext. 42020)

Same-day Appointments

To arrange a same-day visit, call 216.444.CARE (2273)

This information is provided by Cleveland Clinic and is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition.

© Copyright 2014 Cleveland Clinic. All rights reserved.

Cleveland Clinic Mobile Site